NCT04006080 Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis Status UNKNOWN Phase PHASE4
NCT04005144 Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT04002180 Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease] Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03999996 Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose Status COMPLETED Phase PHASE3
NCT03984097 A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Status COMPLETED Phase PHASE1
NCT03961308 A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants Status COMPLETED Phase PHASE1
NCT03961295 A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants Status COMPLETED Phase PHASE1
NCT03949621 A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants Status COMPLETED Phase PHASE1
NCT03948581 A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants Status COMPLETED Phase PHASE1
NCT03943446 A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery Status TERMINATED Phase PHASE2
NCT03942263 A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation Status COMPLETED Phase N/A
NCT03942224 Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03933488 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy Participants Status COMPLETED Phase PHASE1
NCT03889613 Pillcam Crohn's Capsule for Monitoring of Panenteric Mucosal Healing in Crohn's Disease Patients With Vedolizumab Status ACTIVE_NOT_RECRUITING Phase NA
NCT03880123 Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma Status WITHDRAWN Phase PHASE1
NCT03871699 Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart Failure Status UNKNOWN Phase PHASE4
NCT03827655 A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery Status COMPLETED Phase PHASE2